280 related articles for article (PubMed ID: 32852896)
1. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
[TBL] [Abstract][Full Text] [Related]
2. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
[TBL] [Abstract][Full Text] [Related]
3. [Combined histiocytosis of the Langerhans group (Langerhans cell histiocytosis and Erdheim-Chester disease) in a 64-year-old man with BRAF and NRAS mutations: a case report].
Rodríguez-Duque MS; Martín Soler P; González Vela MC; Gómez Román JJ
Rev Esp Patol; 2023; 56(3):186-190. PubMed ID: 37419557
[TBL] [Abstract][Full Text] [Related]
4. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
[TBL] [Abstract][Full Text] [Related]
5. Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms.
Kemps PG; Kester L; Scheijde-Vermeulen MA; van Noesel CJM; Verdijk RM; Diepstra A; van Marion AMW; Dors N; van den Bos C; Bruggink AH; Hogendoorn PCW; van Halteren AGS
Histopathology; 2024 Apr; 84(5):837-846. PubMed ID: 38213281
[TBL] [Abstract][Full Text] [Related]
6. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.
Huang W; Qiu T; Zeng L; Zheng B; Ying J; Feng X
Oncotarget; 2016 Nov; 7(48):78355-78362. PubMed ID: 27823979
[TBL] [Abstract][Full Text] [Related]
7. Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.
Allen CE; Parsons DW
Hematology Am Soc Hematol Educ Program; 2015; 2015():559-64. PubMed ID: 26637772
[TBL] [Abstract][Full Text] [Related]
8. Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells.
Durham BH; Roos-Weil D; Baillou C; Cohen-Aubart F; Yoshimi A; Miyara M; Papo M; Hélias-Rodzewicz Z; Terrones N; Ozkaya N; Dogan A; Rampal R; Urbain F; Le Fèvre L; Diamond EL; Park CY; Papo T; Charlotte F; Gorochov G; Taly V; Bernard OA; Amoura Z; Abdel-Wahab O; Lemoine FM; Haroche J; Emile JF
Blood; 2017 Jul; 130(2):176-180. PubMed ID: 28566492
[TBL] [Abstract][Full Text] [Related]
9. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
[TBL] [Abstract][Full Text] [Related]
10. Induction of histiocytic sarcoma in mouse skeletal muscle.
Liu J; Hettmer S; Milsom MD; Hofmann I; Hua F; Miller C; Bronson RT; Wagers AJ
PLoS One; 2012; 7(8):e44044. PubMed ID: 22952867
[TBL] [Abstract][Full Text] [Related]
11. Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations.
Prabhakaran N; Jour G; Balar A; Ward N
Acta Haematol; 2023; 146(3):245-251. PubMed ID: 36754028
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.
Geerlinks AV; Abla O
Paediatr Drugs; 2023 Jul; 25(4):399-409. PubMed ID: 37204611
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
Milne P; Bigley V; Bacon CM; Néel A; McGovern N; Bomken S; Haniffa M; Diamond EL; Durham BH; Visser J; Hunt D; Gunawardena H; Macheta M; McClain KL; Allen C; Abdel-Wahab O; Collin M
Blood; 2017 Jul; 130(2):167-175. PubMed ID: 28512190
[TBL] [Abstract][Full Text] [Related]
14. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
15. Atypical cutaneous histiocytic eruption in a patient with chronic myelomonocytic leukemia: A case report.
Li JJ; Talam S; Star P; Getta B
J Cutan Pathol; 2021 May; 48(5):680-688. PubMed ID: 33416192
[TBL] [Abstract][Full Text] [Related]
16. The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort.
Ozkaya N; Rosenblum MK; Durham BH; Pichardo JD; Abdel-Wahab O; Hameed MR; Busam KJ; Travis WD; Diamond EL; Dogan A
Mod Pathol; 2018 Apr; 31(4):581-597. PubMed ID: 29192649
[TBL] [Abstract][Full Text] [Related]
17. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma.
Fernandez-Pol S; Bangs CD; Cherry A; Arber DA; Gratzinger D
Hum Pathol; 2016 Sep; 55():39-43. PubMed ID: 27134111
[TBL] [Abstract][Full Text] [Related]
18. Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma.
Shanmugam V; Griffin GK; Jacobsen ED; Fletcher CDM; Sholl LM; Hornick JL
Mod Pathol; 2019 Jun; 32(6):830-843. PubMed ID: 30626916
[TBL] [Abstract][Full Text] [Related]
19. Erdheim-Chester disease associated with chronic myelomonocytic leukemia harboring the same clonal mutation.
Bonnet P; Chasset F; Moguelet P; Abisror N; Itzykson R; Bouaziz JD; Hirsch P; Barbaud A; Haroche J; Mekinian A; Hélias-Rodzewicz Z; Clappier E; Fenaux P; Fain O; Tazi A; Emile JF;
Haematologica; 2019 Nov; 104(11):e530-e533. PubMed ID: 31221777
[No Abstract] [Full Text] [Related]
20. MAPK/ERK signal pathway alterations in patients with Langerhans Cell Histiocytosis.
Novosad O; Skrypets T; Pastushenko Y; Titorenko I; Martynchyk A; Skachkova O; Inomistova M; Gorbach A; Khranovska N; Kryachok I
Klin Onkol; 2018; 31(2):130-136. PubMed ID: 29708356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
